Neural stem cells (NSCs) of the central nervous system (CNS) recently have attracted a great deal of interest not only because of their importance in basic research on neural development, but also in terms of their therapeutic potential in neurological diseases, such as Parkinson's disease (PD). To examine if genetically modified NSCs are a suitable source for the cell and gene therapy of PD, an immortalized mouse NSC line, C17.2, was transduced with tyrosine hydroxylase (TH) gene and with GTP cyclohydrolase 1 (GTPCH1) gene, which are important enzymes in dopamine biosynthesis. The expression of TH in transduced C17.2-THGC cells was confirmed by RT-PCR, Western blot analysis, and immunocytochemistry, and expression of GTPCH1 by RT-PCR. The level of L-DOPA released by C17.2-THGC cells, as determined by HPLC assay, was 3793 pmol/10 6 cells, which is 760-fold higher than that produced by C17.2-TH cells, indicating that GTPCH1 expression is important for L-DOPA production by transduced C17.2 cells. Following the implantation of C17.2-THGcC NSCs into the striata of parkinsonian rats, a marked improvement in amphetamine-induced turning behavior was observed in parkinsonian rats grafted with C17.2-THGC cells but not in the control rats grafted with C17.2 cells. These results indicate that genetically modified NSCs grafted into the brain of the parkinsonian rats are capable of survival, migration, and neuronal differentiation. Collectively, these results suggest that NSCs have great potential as a source of cells for cell therapy and an effective vehicle for therapeutic gene transfer in Parkinson's disease.
INTRODUCTION
problems in acquiring fetal tissues. To circumvent these difficulties, it is necessary to procure alternative source Cell replacement and gene transfer to the diseased or of cells producing dopamine (DA) or L-dihydroxypheinjured central nervous system (CNS) provide the basis nylalanine (L-DOPA), a DA precursor (24) . Earlier studfor the development of potentially powerful new theraies have focused on the development of genetically engipeutic strategies for use in a broad spectrum of human neered cell lines overexpressing tyrosine hydroxylase neurodegenerative disorders. Parkinson's disease (PD) is (TH), which is a rate-limiting enzyme in catecholamine an attractive target for these therapeutic approaches bebiosynthesis (11, 36) . However, parkinsonian animal modcause the degeneration and cell death of dopaminergic els grafted with genetically modified cells containing the neurons in substantia nigra pars compacta is well charac-TH gene alone have shown only partial restoration of terized (2, 18) . Previous studies have reported that the behavioral and biochemical deficits (25). The limited implantation of fetal ventral mesencephalic cells into the success of this approach is related to the limited availcaudate and putament of PD patients provided a marked ability of cofactor, tetrahydrobiopterin (BH 4 ), because improvement in clinical course in these patients (22, 33) .
neither the dopamine-depleted striatum nor the various However, this therapeutic approach has faced with grave cells used for gene transfer contained sufficient BH4 to limitations because of ethical, religious, and logistical support TH activity (21, 30) . Therefore, it is necessary to transfer the GTP cyclohydrolase 1 (GTPCH1) gene, which pressing β-galactosidase were plated in 60-mm dishes at 1 × 10 6 cells per dish, infected with the retrovirus ex-is the first and rate-limiting enzyme in the BH 4 biosynthetic pathway (32) . Despite these efforts, the transplan-pressing TH (pBabe-puro-HTH, Fig. 1A ) for 2 h at 37°C, and incubated with medium containing 25 µg/ml tation of genetically engineered cells in animal models of PD has not provided conclusive long-term beneficial of DEAE-dextran for 30 min. Forty-eight hours later, medium was replaced with 5 ml of fresh medium con-effects or a marked increase in the production of L-DOPA (4, 20) . taining 5 µg/ml puromycin. After 10 days, puromycinresistant cells were trypsinized and cultured by limiting The successful application of in vivo gene transfer to the CNS will depend partly on the identification of suit-dilution in a 96-well plate. Twenty C17.2 cell clones were evaluated by Northern and Western blotting for TH able cells that can serve as carriers for a wide range of potentially therapeutic transgenes, and provide suitable expression, and one high expresser clone was selected and designated as C17.2-TH. C17.2-TH cells were infected platforms for the functionally efficient expression and secretion of transgene products. The recently introduced with the retrovirus expressing GTPCH1 (p∆gHCGC, Fig.  1B ) as described above, and clones carrying GTPCH1 immortalized CNS-derived neural stem cells (NSCs) are interesting candidates in this context (7, 12, 13, 27) . NSC gene were selected by addition of 200 µg/ml hygromycin in the medium. The surviving clones expressing transplantation has the potential to prevent or restore the anatomical and functional deficits associated with injury highest levels of TH and GTPCH1, referred to as C17.2-TH.GC, were established. or disease in the CNS via cell replacement, and to induce the release of specific neurotransmitters and/or the RT-PCR Analysis production of trophic factors that promote neuronal growth and regeneration (6, 12, 26) . The C17.2 cell line Cells were collected by centrifugation and total RNA was isolated using Trizol, according to the manufactur-is a clonal, multipotent mouse NSC line (38, 39) , which has the ability to self-renew, differentiate into cells of er's protocol (Promega, Madison, WI). One microgram of total RNA was reverse-transcribed into first-strand neuronal and glial lineages, and populate the developing or degenerating CNS (37) . In the present study, C17.2 cDNA using oligo-dT primer. Reverse transcription was performed with M-MLV reverse transcriptase (Promega) NSCs were genetically engineered to produce L-DOPA by double transduction with the cDNAs for human TH for 1 h at 42°C, inactivated for 10 min at 95°C, and cooled to 4°C. The cDNA was diluted to a final volume and rat GTPCH1. It was found that the transplantation of these cells led to an enhanced TH function in vivo and of 25 µl, and a 2-µl aliquot was used in a PCR reaction containing 1× DNA polymerase buffer, 1.5 mM MgCl 2 , induced long-term functional recovery following intrastriatal transplantation in a hemiparkinsonian rat model. 0.2 mM dNTPs, 10 pmol primers, 2.5 units of Taq polymerase (Promega). The cDNA was amplified using 30 MATERIALS AND METHODS PCR cycles. Control RT-PCR reactions were carried out Production of Retroviral Vectors Expressing TH using primers specific to GAPDH. The primers used for or GTPCH1 Gene TH and GTPCH1 were as follows: TH (313 bp), 5′-TCCTCCAGCTGGGGGATATTGTCTTC-3′ (sense) and Human TH cDNA fragment of 1.9 kb was inserted 5′-AAGGTCCCCTGGTTCCCAAGAAAAGT-3′ (antiinto the EcoRI site of Moloney murine leukemia virussense); GTPCH1 (288 bp), 5′-GACATGTTTTCCATG derived retroviral vector, pBabe-puro (29), downstream TGTGA-3′ (sense) and 5′-TAGCATGGTGCTAGTGA of the long terminal repeat promoter (LTR) ( Fig. 1A) .
CAG-3′ (antisense). The 0.9-kb BamHI-HincII blunt-ended fragment of rat GTPCH1 cDNA (15) was inserted into the BglII-ClaI
Western Blot Analysis blunt-ended sites of p∆gHCX under the control of cyto-Cells were washed twice in phosphate-buffered saline megalovirus (CMV) promoter ( Fig. 1B) . Whereas p∆-(PBS), lysed by adding 0.6 ml (per 100 cm plate) of gHCX contains the gene for hygromycin-B-phospho-RIPA buffer; 10 µl of 10 mg/ml PMSF was added, and transferase (HPH) as a selectable marker, pBabe-puro incubation was continued for 60 min on ice. Cell lysate contains the gene for puromycin N-acetyl transferase samples were heated to 100°C for 5 min, cooled on ice, (puro) (Fig. 1 ). The production of viral producers from microcentrifuged for 5 min, and 20 µl was loaded into a retroviral packaging cell line PA317 has been described SDS-PAGE gel. Protein concentrations were determined previously (29). All selected producer clones had a titer using a protein assay kit (BioRad, Hercules, CA). Nitroof >1 × 10 5 pfu/ml. cellulose blots were immunolabeled for TH using a rab-Transduction of C17.2 NSC Line With TH bit polyclonal antibody against TH (1:4000, Pel-Freez) and GTPCH1 Genes and for enhanced chemiluminescence (Amersham, Arlington Heights, IL). After washing three 10-min washes The establishment and culture of the C17.2 NSC cell line has been described previously (39) . C17.2 NSCs ex-with an excess volume of TBST, proteins were detected by using an ECL chemiluminescence assay (Amersham). buffer, and L-DOPA was eluted by adding 400 µl of 0.1 M PCA solution. The above two samples (20 µl) were The bands recognized by the primary antibody were visualized by exposure to X-ray film.
then injected into an autosampler at 4°C (Waters 717 plus autosampler) and their L-DOPA and DA contents Immunocytochemistry determined. Peaks were integrated using a commercially Immunocytochemistry for C17.2 NSCs was peravailable program (Breeze, Waters Corp.). formed with cells grown on 12-mm round poly-D-lysine-6-Hydroxydopamine Lesions and the Rotational coated Aclar fluorocarbon plastic coverslips (SPL, Su-Behavior Test won, Korea). Coverslips carrying cells were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer for 15 min Female Sprague-Dawley rats (Samtako, Osan, Korea), weighing approximately 250 g at the start of the at room temperature, permeabilized with 0.2% Triton X-100 for 5 min, and blocked with 10% goat serum in PBS experiment, were subjected to 6-hydroxydopamine (6-OHDA) to remove the dopaminergic input from the ipsi-for 1 h. Cells were then incubated at 4°C overnight with a polyclonal antibody against TH (1:500, Pel-Freez).
lateral substantia nigra to the striatum, as described previously (3). Rats were anesthetized deeply with chloral After washing with PBS three times, coverslips were incubated with biotinylated goat anti-rabbit IgG in PBS/ hydrate (400 mg/kg, IP) and 6-OHDA (Sigma, 3 µg free base/µl dissolved in 0.9% saline supplemented with 0.2 5% goat serum/0.2% Triton X-100 for 1 h at room temperature (RT), reaction with an avidin-biotin-peroxidase mg/ml ascorbic acid), which was injected into the right ascending mesostriatal pathway. Two deposits of 2.5 µl complex (Vectastain ABC kit, Vector) for 1 h at RT. Diaminobenzidine (Sigma, St. Louis, MO) was used to 6-OHDA were made at the following coordinates: (i) A, 
High-Performance Liquid Chromatography (HPLC)
After infusion, the cannula was left in place for 5 min The levels of L-DOPA and DA were analyzed by reto allow toxin diffusion. Three weeks later, the rats were verse-phase HPLC using a C18 (3 × 80 mm, ESA) and monitored for amphetamine-induced rotational asymmean ESA Coulochem II electrochemical detector. To meatry (2.5 mg D-amphetamine sulfate/kg body weight in sure intracellular L-DOPA levels, collected cells were saline, IP) in an automated rotometer bowl (Buwon, sonicated in 400 µl of ice-cold 0.1 M perchloric acid Seoul, Korea) for 90 min. Only rats with more than 15 (PCA) containing 0.1 mM EDTA and supernatants obnet ipsilateral full turns per minute were selected for the tained by the centrifugation cell suspension were filtransplantation experiment. Amphetamine-induced rotatered. Filtrates were analyzed immediately by HPLC. To tional behavior was examined again at 2, 4, 8, 10, 12, quantify dopamine release into the medium, 3 ml of cul-16, and 20 weeks posttransplantation. ture medium (2-h incubation of C17.2 cells) was placed Preparation of Cells and Transplantation Surgery in a tube and mixed thoroughly with 3 M Tris-EDTA (pH 8.6) (7 ml) and aluminum oxide 90 powder (180 C17.2, C17.2-TH, and C17.2-THGC NSCs were harvested by trypsinization, washed twice with PBS, and mg). The powder was then washed twice with Tris suspended in Hanks balanced salt solution (HBSS). The ANOVA using Instat 3.05 (GraphPad software), followed by Student-Newman-Keuls analyses. cell density was adjusted to 2.5 × 10 5 cells/µl HBSS based on hemocytometer cell counts. Recipient rats were RESULTS divided into three groups according to the cells grafted:
Characterization of NSCs Transduced (i) rats grafted with control nontransduced C17. 2 
cells
With TH and GTPCH1 (n = 6), (ii) rats grafted with C17.2-TH cells transduced with the hTH gene (n = 8), and (iii) rats grafted with C17.2 NSCs transduced with retroviral vectors ex-C17.2-THGC cells cotransduced with hTH and the rat pressing TH and GTPCH1 showed no phenotypic differ-GTPCH1 gene (n = 8). Under anesthesia (see 6-OHDA ences versus parental NSCs (Fig. 2C) , and no apparent lesions above), two injections of a 2 µl cell suspension changes in cell growth or morphology. TH expression were stereotactically injected, at the following coordiin transduced C17.2 cells was confirmed by RT-PCR, nates: (i) A, +1.0; L, +3.0; V, +5.0; and (ii) A, +0.6; L, Western blot analysis, and immunocytochemistry. +2.0; V, +4.5. The tooth bar was set at 0, and the ventral RT-PCR results showed that a TH band of the ex-(V) coordinate was measured from the dural surface. A pected size (313 bp) was amplified in TH-transduced total of 10 6 cells was injected, divided equally between C17.2-TH and C17.2-THGC NSCs and a GTPCH1 fragthe two injection sites. The injection speed was 1 µl/ ment of 288 bp was detected in C17.2-THGC NSCs min, and the cannula was withdrawn after a 10-min ( Fig. 2A ). Expression of TH proteins was identified by waiting period. Cyclosporin A (Novartis, Seoul, Korea)
Western blot analysis in both C17.2-TH and C17.2dissolved in olive oil (Sigma) at a concentration of 1 THGC NSC lines (Fig. 2B ). In C17.2-TH and C17.2mg/ml was given to rats receiving xenografts (10 µg/ TH.GC cells, a TH band of 56 kDa was strongly exg body weight) intraperitoneally daily from the day of pressed, which is consistent with the molecular weight transplantation until sacrifice.
of TH from rat SN and striatum samples. All cell types (C17.2, C17.2-TH, C17.2-GC, and C17.2-THGC) were Tissue Processing, TH Immunohistochemistry, tested for immunoreactivity with a TH-specific polyand X-gal Staining clonal antibody. Both C17.2-TH and C17.2-THGC cells were found to be immunoreactive for TH, whereas the TH immunohistochemistry was performed at 4, 12, control C17.2 and C17.2-GC cells were not (Fig. 2C ). and 20 weeks after transplanting the three groups of
The intensity of the staining in C17.2-TH and C17.2-C17.2 cells. Rats were deeply anesthetized with chloral THGC cells in culture was stable throughout all pashydrate and transcardially perfused with isotonic saline sages (data not shown). and ice-cold 4% paraformaldehyde. The brains were removed, immersed in 20% sucrose in 0.1 M phosphate
In Vitro DOPA Release buffer at 4°C, and then frozen and sectioned coronally
The contents of L-DOPA and DA in cells and media at 40 µm on a cryostat (Leica CM 3000) throughout the were measured by HPLC-ECD ( Fig. 3 ). While the level striatum (Fig. 5A) ; a consecutive series of six sections/ of L-DOPA production was 5 pmol/10 6 cells in culture brain was prepared for further processing. Adjacent brain medium of C17.2.TH cells, L-DOPA production was sections were processed for TH immunohistochemistry, 3.79 nmol/10 6 cells (a 760-fold increase) for C17.2using a previously described protocol (8) . After rinsing TH.GC cells, indicating that the TH enzyme gene transin PBS, the brain sections were incubated with a primary duced in C17.2 cells was functional and that GTPCH1 rabbit anti-TH polyclonal antibody (1:500, Pel-Freez) expression is required to obtain L-DOPA production and overnight at RT, followed by an avidin-biotin complex release in C17.2 NSCs. In contrast, L-DOPA levels in system (Vectastain ABC kit, Vector) and 0.05% DAB cell homogenates was very low or undetectable in all as a chromogen. After rinsing in PBS, the sections were samples (data not shown), showing that synthesized Lmounted onto gelatin-coated slides. β-Galactosidase was DOPA is released by these cells into the culture medetected by incubating brain sections for 3 h at 37°C in dium. In addition, DA synthesis was not detected in all reaction solution consisting of PBS containing 4 mM cell types. potassium ferricyanide (Sigma), 4 mM potassium ferrocyanide (Sigma), 4 mM magnesium chloride (Sigma), Rotational Behaviors of Parkinsonian Rats and 0.4 mg/ml 5-bromo-4-chloro-3-indolyl β-D-galacto-With NSCs Transplantation side (X-gal, Sigma).
Rotation behavior in response to amphetamine administration was monitored in all rats including sham-Statistical Analysis operated (n = 6) and grafted animals (n = 8 in each group), at 2, 4, 8, 10, 12, 16, and 20 weeks after trans-All values are expressed as means ± SEM. Statistical significance ( p < 0.05, for all analyses) was assessed by plantation ( Fig. 4 ). Rats grafted with 10 6 cells of C17.2.TH (n = 8) showed only slight recovery versus duced with TH and GTPCH1 gene for up to 20 weeks after transplantation. control rats in terms of rotation behavior. In contrast, a marked long-term recovery in rotation behavior was Survival and Differentiation of NSCs observed in five of eight rats grafted with C17.2-TH.GC After Transplantation cells. The remaining three rats in this group failed to recover. A significant recovery in rotation behavior was One week after transplantation, numerous β-galactosidase-positive cells along the paths of transplantation observed in the rats grafted with C17.2-THGC NSCs ( p < 0.001). A continuous improvement in rotation be-within the brain, and migrating cells from the graft sites were found (Fig. 5B) . These migrating cells showed var-havior was exhibited by rats grafted with cells cotrans-ronal morphology (Fig. 5D ). In addition, TH-positive cells showed dense networks of fibers and cells within the injection sites and extending into the surrounding host striatum (Fig. 5E ). TH-immunoreactive cells were not detected in striatum of rats grafted with control C17.2 cells (Fig. 5G) .
At 12 and 20 weeks after transplantation, in rats grafted with C17.2-THGC cells, there was considerable reduction in TH staining along the paths of cell transplantation (Fig. 5H, I) . Interestingly, many grafted cells were found to migrate some distance from the transplanted sites in rats showing behavioral improvement. However, in rats that did not show motor behavioral improvement, most of the grafted cells were trapped inside pockets ( Fig. 5J) and TH immunoreactivity did not extend into the surrounding host striatum. lineages, and populate the developing or degenerating CNS following implantation (38, 39) . Previous studies have shown that C17.2 NSCs participate in normal cere-ious morphological features including cells with long processes indicative of neurons (Fig. 5C ).
bellar development in an architecturally appropriate, nontumorigenic manner, and differentiate into multiple At 4 weeks after the transplantation, most of C17.2-TH.GC NSCs expressing TH remained within the graft cerebellar cell types (39) and that C17.2 NSCs differentiate into oligodendrocytes, forming new myelin sheath sites, but some cells were also observed to migrate (Fig.  5F ). Some cells expressing TH showed a mature neu-following transplantation into the brain of dysmyelina- In rats grafted with C17.2-TH.GC, five of eight rats showed more than a 50% decline in rotation at 4 weeks postgrafting, and this reduction in rotation continued for 12 weeks. Three rats showed no evidence of behavioral recovery. In animals grafted with C17.2 parental cells and C17.2-TH cells, no behavioral improvement was noted. *p < 0.001. tion mutant shiverer (40) . It has been also demonstrated (AADC), the DOPA-decarboxylating enzyme, which is required to convert DOPA to DA (31). For these cells that C17.2 NSCs carrying prodrug-converting enzyme gene penetrate selectively into the brain tumor mass and to exert any DA effects in vivo, L-DOPA must be converted to DA in the host brain tissue surrounding grafted effectively deliver an oncolytic agent to kill tumor cells (1) . C17.2 cells overexpressing neurotrophin-3 were L-DOPA-producing cells. This probably occurred in the present study, because the host striatal cells, both neu-found to survive for up to 2 months, migrate, and differentiate into cells with neuronal and glial phenotypes rons and glia, are known to contain relatively high levels of AADC even after nigrostriatal denervation. after transplantation into the rat spinal cord (23).
In the present study, C17.2 NSCs were doubly trans-Evidence for the in vivo expression of the TH transgene in C17.2-THGC NSCs was obtained by TH immu-duced with human TH gene and GTPCH1 gene, and selected with two different markers (puromycin and hy-nohistochemistry and by assessing rotational behavioral in the unilateral 6-OHDA lesion model. Previous studies gromycin). The expression of TH and GTPCH1 in the transduced C17.2-THGC cells was confirmed by RT- have reported that the long-term expression of transduced gene is difficult, even in NSCs, as gene expres-PCR and Western blots, and significant levels of L-DOPA biosynthesis in C17.2-THGC cells was determined sion is downregulated during NSC differentiation with time (5, 12) . In the present study, however, good survival by HPLC. The amount of L-DOPA secreted into the culture medium by C17.2-THGC was 3.8 nmol/10 6 cells of TH transduced NSCs in the brain of hemiparkinsonian rats was demonstrated. Grafted C17.2-THGC NSCs and corresponds to a 760-fold increase over parental C17.2-TH cells. Whereas TH-transduced fibroblasts were found to contain relatively high levels of TH, and some migrated away from the injection sites into the (10, 16) or TH-transduced astrocytes (25) required addition of exogenous tetrahydrobiopterin (BH 4 ), a cofactor surrounding host tissues, and a dense network of THpositive fibers and cells within the transplant and sur-to allow the TH enzyme to function and to synthesize L-DOPA, C17.2 NSCs transduced with both TH and rounding host striatum was demonstrated. Moreover, the significant reduction in amphetamine-induced turning GTPCH1 genes synthesized L-DOPA without BH 4 addition. Previous studies have also shown that neither BH 4 behavior after brain implantation of C17.2-THGC NSCs was as effective in magnitude as that previously reported nor L-DOPA production was found in a variety of cell types tranduced only with the TH gene, including fibro-using either ex vivo gene transfer using cells (3, 10, 16) or in vivo gene transfer using viral vectors (9, 17) . It blasts (10, 16) , astrocytes (25), and Schwann cells (34) , indicating that the presence of both TH and GTPCH1 appears that the observed improvement in motor behavior by brain transplantation of C17.2-THGC NSCs is re-genes is critical in production of L-DOPA in genetically modified cells. The levels of L-DOPA production in lated to the capacity of grafted NSCs to make reciprocal connections within the host tissue. This was confirmed fetal mouse mesencephalic neural cell line (3), THtransduced fibroblasts (10, 16) , astrocytes (25), or Schwann by TH immunohistochemistry; a number of TH-positive cells and fibers survived in the striatum of animals that cells (34) as reported previously are much lower than the amount in the present study. While tumor cell lines showed a reduction in amphetamine-induced rotation. Previous studies have shown that genetically modified produce sufficient amounts of endogenous BH 4 , other cell types, including fibroblasts, astrocytes, Schwann nonneuronal cells are effective only in the short term in animal models of PD (3, 10, 16) , which highlights the cells, and muscle cells, produce L-DOPA only when exogenous BH 4 is added (10, 16, 25, 34) . A previous study importance of connectivity for long-term functional recovery, because these primary nonneuronal cell types do has shown that this problem could be circumvented by the coexpression of TH and GTPCH1, with the latter not have the ability to make reciprocal connections with host tissue. Compared with the other primary cells used responsible for the synthesis of BH 4 cofactor. Thus, in the present study, we cotransduced C17.2 NSCs with so far to transfer the TH gene (fibroblasts and muscle cells), NSCs have the advantage that they are CNS de-TH and GTPCH1 to produce C17.2-THGC, which biosynthesizes high levels of L-DOPA in vitro without the rived, and thus are normal constituents of the CNS and have the ability to survive and integrate in the adult addition of exogenous BH 4 . The level of L-DOPA content in C17.2-TH.GC is 760-fold higher over that in CNS. In contrast to earlier studies, which found that immortalized cell lines either formed tumors shortly after C17.2-TH. It is interesting to note that none of the cells described in the studies cited above has shown evidence grafting (19) or were attacked by the host immune system (8, 14) , the C17.2-THGC NSCs neither led to tumor of dopamine (DA) production. Even though astrocytes in the host striata carry enzymes and cofactors that are formation nor showed signs of rejection. The present study shows that the NSCs doubly transduced with GTPCH1 and essential for DA production, the reason for the failure in DA production in previous experimental trials probably TH are an effective alternative for cell therapy in PD in place of DA neurons isolated from fetal midbrain. In is insufficiency of aromatic amino acid decarboxylase
